News

 
12/02/2021

The BoLe Chronicle | February 2021

Asian High Yield: more than just a yield play   How many times have we heard stories of...
 
11/02/2021

Equity takes-off thanks to the reporting season

The current American reporting season confirms that the earnings bottom is now behind us. This was...
 
05/02/2021

Playing the commodity card with semiconductors

The sector, one of the “thoroughbreds of 2021”, has cheaper valuations than the...
 
21/01/2021

There is life beyond growth

Reali (Pharus): “In some segments of the market we are seeing excessive optimism and...
 
17/12/2020

Pharus Outlook 2021

Effects of the crisis   There is just one ingredient that can give the necessary boost...
 
15/12/2020

The Bole Chronicle | December 2020

Volatility as an all-weather strategy in Asia   Horror stories dominate when it...
 
03/12/2020

Pharus Sicav - Classes name modification as of December 2020

Pharus Sicav, with the release of the new Prospectus in December, changed the name of the classes...
 
30/11/2020

Pharus Sicav Absolute Return changes its name to Pharus Sicav Conservative

The name of the sub-fund changes, but the strategy remains the same.   The new name,...
 
30/11/2020

Pharus Sicav Biotech changes its name to Pharus Sicav Medical Innovation

The fund, focused on companies operating in the biotechnology sector and at the forefront in the...